Compounds > 1,2-dipalmitoylphosphatidylcholine
Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and gemcitabine

1,2-dipalmitoylphosphatidylcholine has been researched along with gemcitabine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amenitsch, H; Bourgaux, C; Couvreur, P; Desmaële, D; Keller, G; Lepêtre-Mouelhi, S; Ollivon, M; Pili, B1
Casale, F; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D1
Arpicco, S; Beghelli, S; Costanzo, C; Dalla Pozza, E; Dando, I; Donadelli, M; Fattal, E; Lerda, C; Palmieri, M; Scarpa, A; Scupoli, MT; Zoratti, E1

Other Studies

3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and gemcitabine

ArticleYear
Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.
    Biochimica et biophysica acta, 2010, Volume: 1798, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Calorimetry, Differential Scanning; Deoxycytidine; Gemcitabine; Lipid Bilayers; Membranes, Artificial; Phase Transition; Prodrugs; Scattering, Radiation; Scattering, Small Angle; Squalene; Transition Temperature; X-Ray Diffraction

2010
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Colloids; Deoxycytidine; Dose-Response Relationship, Drug; Drug Compounding; Fatty Acids, Monounsaturated; Female; Gemcitabine; Humans; Kinetics; Lipids; Liposomes; Particle Size; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Quaternary Ammonium Compounds; Selective Estrogen Receptor Modulators; Solubility; Tamoxifen; Technology, Pharmaceutical

2012
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
    Biochimica et biophysica acta, 2013, Volume: 1828, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cholesterol; Deoxycytidine; Flow Cytometry; Gemcitabine; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Mice; Mice, Nude; Microscopy, Confocal; Pancreatic Neoplasms; Phosphatidylethanolamines; Prodrugs; Tumor Burden; Xenograft Model Antitumor Assays

2013